Literature DB >> 12145781

The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.

Kenneth R Wilund1, Perry L Colvin, Dana Phares, Andrew P Goldberg, James M Hagberg.   

Abstract

The effect of 6 months of endurance exercise training on plasma concentrations of lipoprotein (Lp)AI and LpAI:AII was determined in 39 sedentary subjects (17 men, 22 women, average age, 57 years) with abnormal cholesterol concentrations (total cholesterol [TC] > 200 mg/dL, or high-density lipoprotein-cholesterol [HDL-C] < 35 mg/dL). Following exercise training, plasma LpAI concentrations increased (+5.9 +/- 1.2 mg/dL; P <.001), but there was no change in total apolipoprotein (apo) A-I or LpAI:AII concentrations. The change in plasma LpAI concentration was positively correlated to changes in total HDL-C (r =.495, P =.001), the sum of HDL4-C(nmr) + HDL5-C(nmr) (r =.417, P =.008), and average HDL particle size (r =.415, P =.009), but not to changes in body composition or Vo2max. In the 8 subjects with the greatest change in LpAI concentration following training, the size distribution of LpAI and LpAI:AII particles in plasma also was measured before and after training. In these subjects, the size distribution of LpAI:AII particles did not change with training, but there was a significant increase (0.1 nm; P =.048) in the peak size of the "medium" (7.8 to 9.8 nm) LpAI particles after training. In 7 subjects who served as age- and weight-matched sedentary controls, plasma concentrations of total apo A-I, the LpAI and LpAI:AII subfractions, and plasma lipoprotein-lipids did not differ significantly between baseline and final testing. These data indicate that endurance exercise training increases the average size and plasma concentrations of LpAI, but not LpAI:AII, particles, which may represent possible enhancements of reverse cholesterol transport and may provide insight into the role that exercise plays in reducing cardiovascular disease risk. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145781     DOI: 10.1053/meta.2002.33356

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  Optimizing management of metabolic syndrome to reduce risk: focus on life-style.

Authors:  Cristina Bianchi; Giuseppe Penno; Giuseppe Daniele; Luca Benzi; Stefano Del Prato; Roberto Miccoli
Journal:  Intern Emerg Med       Date:  2008-02-13       Impact factor: 3.397

2.  Adverse Cardiovascular Response to Aerobic Exercise Training: Is This a Concern?

Authors:  Eric S Leifer; Catherine R Mikus; Laura Karavirta; Benjamin D Resnick; William E Kraus; Keijo Häkkinen; Conrad P Earnest; Jerome L Fleg
Journal:  Med Sci Sports Exerc       Date:  2016-01       Impact factor: 5.411

3.  Endurance training enhances ABCA1 expression in rat small intestine.

Authors:  Behzad Mehdi Khabazian; Abbass Ghanbari-Niaki; Ali reza Safarzadeh-Golpordesari; Mehdi Ebrahimi; Fatemeh Rahbarizadeh; Hossein Abednazari
Journal:  Eur J Appl Physiol       Date:  2009-07-24       Impact factor: 3.078

4.  C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels.

Authors:  Thomas O Obisesan; Christiaan Leeuwenburgh; Tracey Phillips; Robert E Ferrell; Dana A Phares; Steven J Prior; James M Hagberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-22       Impact factor: 8.311

5.  C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity.

Authors:  Thomas O Obisesan; Christiaan Leeuwenburgh; Robert E Ferrell; Dana A Phares; Jennifer A McKenzie; Steven J Prior; James M Hagberg
Journal:  Metabolism       Date:  2006-04       Impact factor: 8.694

6.  Adverse metabolic response to regular exercise: is it a rare or common occurrence?

Authors:  Claude Bouchard; Steven N Blair; Timothy S Church; Conrad P Earnest; James M Hagberg; Keijo Häkkinen; Nathan T Jenkins; Laura Karavirta; William E Kraus; Arthur S Leon; D C Rao; Mark A Sarzynski; James S Skinner; Cris A Slentz; Tuomo Rankinen
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

7.  Endurance versus resistance training in treatment of cardiovascular risk factors: A randomized cross-over trial.

Authors:  Hannah J Thomas; Channa E Marsh; Barbara A Maslen; Leanne Lester; Louise H Naylor; Daniel J Green
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.